Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Infection and Drug Resistance | journal | 0.966 Q1 | 65 | 390 | 350 | 15234 | 1171 | 341 | 3.31 | 39.06 | |
2 | Drug Design, Development and Therapy | journal | 0.880 Q2 | 94 | 379 | 1064 | 15240 | 3576 | 1044 | 3.44 | 40.21 | |
3 | Diabetes, Metabolic Syndrome and Obesity | journal | 0.862 Q2 | 64 | 254 | 187 | 11039 | 612 | 181 | 3.04 | 43.46 | |
4 | Pharmacogenomics and Personalized Medicine | journal | 0.967 Q1 | 37 | 34 | 69 | 2240 | 271 | 66 | 3.76 | 65.88 | |
5 | Biomarker Insights | journal | 1.253 Q1 | 40 | 16 | 73 | 836 | 288 | 73 | 3.84 | 52.25 | |
6 | Journal of Experimental Pharmacology | journal | 0.803 Q2 | 23 | 16 | 26 | 619 | 81 | 26 | 3.78 | 38.69 | |
7 | Drug, Healthcare and Patient Safety | journal | 0.473 Q3 | 30 | 15 | 35 | 565 | 72 | 35 | 1.91 | 37.67 | |
8 | Clinical Medicine Insights: Therapeutics | journal | 0.206 Q3 | 11 | 1 | 37 | 21 | 32 | 37 | 0.75 | 21.00 | |
9 | Core Evidence (discontinued) | journal | 1.054 Q1 | 29 | 0 | 10 | 0 | 53 | 10 | 5.60 | 0.00 | |
10 | Journal of Receptor, Ligand and Channel Research | journal | 0.168 Q4 | 13 | 0 | 3 | 0 | 3 | 3 | 0.50 | 0.00 | |
11 | Perspectives in Medicinal Chemistry | journal | 4.450 Q1 | 17 | 0 | 2 | 0 | 31 | 2 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®